Quick Answer
Nuvation Bio Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $62.90 million for the year ending 2025.
- Nuvation Bio Inc. showed an increase of +699.0% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from Nuvation Bio Inc.'s annual report (Form 10-K), filed with the SEC on March 2, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $62.90 million | Fiscal year 2024: $7.87 million | Fiscal year 2023: $0.00.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: